# Endpoint Health Inc.

Canonical: https://abierto.us/vendors/endpoint-health-inc-vxk3h62wkfm1

- UEI: VXK3H62WKFM1
- CAGE: 8L2B3
- Location: Palo Alto, CA
- Awards in window: 1 (2 transactions), $0 obligated, January 24, 2024 to April 18, 2024

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 1 awards, $0

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $0

## Competition

- Competed Under SAP: 1 awards

## Largest awards

- 75A50122C00058 (definitive contract): $0, Barda - Aspr / Daappo / Barda DCMA. Endpoint: Gene Expression Scoring of Immune Activity Levels for Precision Use of Hydrocortisone in Septic Shock: Secondary Analysis of the Adrenal Trial Aoi #02: Infection Severity and Solving Sepsis. https://www.usaspending.gov/award/CONT_AWD_75A50122C00058_7505_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/endpoint-health-inc-vxk3h62wkfm1.